Exploiting biomedical literature to mine out a large multimodal dataset of rare cancer studies

The overall lower survival rate of patients with rare cancers can be explained, among other factors, by the limitations resulting from the scarce available information about them. Large biomedical data repositories, such as PubMed Central Open Access (PMC-OA), have been made freely available to the scientific community and could be exploited to advance the clinical assessment of these diseases. A multimodal approach using visual deep learning...